Shed vs IVIM Health: Coaching and Compounded GLP-1 Compared

Quick verdict: Shed vs IVIM Health

The core difference in this Shed vs IVIM Health comparison is service model: Shed pairs name-brand and compounded GLP-1 with continuous coaching and a 2-minute approval assessment; IVIM Health focuses on compounded GLP-1 with a clinician-guided GLP-1 ID protocol and strong third-party ratings. Early verdict: choose Shed if you want name-brand options plus coaching; choose IVIM Health if you prioritize low starting cost and verified external reviews.

Explore Shed’s dual name-brand and compounded options

How they differ: five comparison areas

This direct comparison uses only supplied facts to highlight the most distinctive differences: medication type availability, coaching and protocols, pricing and introductory offers, assessment/consultation process, and external validation and clinical claims.

1. Medication types: name-brand plus compounded vs compounded only

Shed: Offers both FDA-approved name-brand GLP-1 medications and compounded GLP-1 options on one platform, letting patients choose based on budget and preference. The source notes that name-brand options carry higher costs and that compounded medications are not FDA-approved and are prepared by a licensed pharmacy based on a provider’s prescription.

IVIM Health: Offers compounded semaglutide and tirzepatide formulations only. The source emphasizes that compounded drugs are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality.

2. Coaching and clinical protocols

Shed: Integrates continuous coaching into treatment, describing coaching as part of every treatment plan rather than a separate service. The platform positions coaching as support through titration and lifestyle changes.

IVIM Health: Uses a proprietary GLP-1 ID clinician-guided titration and optimization protocol, which the platform says can accelerate weight loss outcomes by up to 40% compared to standard GLP-1 protocols. The 40% figure is presented in the source as IVIM’s own claim and not an independent clinical finding.

3. Pricing and introductory offers

Shed: Lists compounded semaglutide injections starting at $199/month and compounded tirzepatide injections starting at $299/month. The source also notes a limited time offer of 10% off your first month and that standard pricing is not published until you receive a personalized quote.

IVIM Health: Shows a $75/month starting figure on captured landing-page evidence for semaglutide and $133/month for tirzepatide with an additional $74.99/month program fee in described materials. The provider offers a free month membership with code GIFT75 and a no-obligation free consultation valued at $75 for new patients.

4. Assessment and consult process

Shed: Promotes a 2-minute online approval assessment to check eligibility quickly, followed by clinician review before any prescription is issued.

IVIM Health: Provides a no-obligation free consultation for new patients (a $75 value) during which a licensed IVIM clinician evaluates weight-loss history, goals, and medical profile. The source states a prescription is required after clinical evaluation.

5. External validation and clinical claims

Shed: Emphasizes its combined offering of name-brand and compounded options plus coaching as its differentiator versus competitors; the source references clinical trial weight-loss figures for Wegovy referenced in terms and conditions but notes results may vary and to see full terms.

IVIM Health: Highlights a dual 4.9-star rating on Google and Trustpilot as an unusually strong satisfaction signal. IVIM also cites retrospective observational studies and internal published data supporting its protocol, while clearly noting these are not head-to-head randomized trials and that results may vary.

Comparison table: Shed vs IVIM Health

See IVIM Health’s free consult and GIFT75 offer

Clinical evidence and limits

Both providers note that compounded medications are not FDA-approved and results may vary. Shed references Wegovy clinical trial averages in its terms but frames them as trial results requiring diet and exercise and says to see terms for full details. IVIM includes retrospective observational studies and internal data supporting its protocol but specifies these are not randomized head-to-head trials and that outcomes may vary.

Start Shed’s 2-minute assessment

Bottom line and who should pick which

In short, this Shed vs IVIM Health comparison shows Shed is focused on offering name-brand options plus compounded drugs with integrated coaching and a rapid online assessment. IVIM Health emphasizes low starting pricing for compounded formulas, a no-obligation free consult, a clinician-guided GLP-1 ID protocol, and unusually strong third-party review scores.

Check IVIM Health pricing and reviews

Choose Shed if…

• You want access to both FDA-approved name-brand GLP-1 and compounded options on one platform.
• You value continuous coaching integrated into treatment rather than a prescription-only model.
• You prefer a fast 2-minute online eligibility assessment followed by clinician review.

Choose IVIM Health if…

• You prioritize lower advertised starting rates for compounded semaglutide and a free consult to reduce upfront cost.
• You want a clinician-guided, proprietary GLP-1 ID protocol and strong external reviews (4.9 stars on Google and Trustpilot).

Primary keyword: Shed vs IVIM Health